Results 161 to 170 of about 13,667 (181)

Harnessing conserved epitopes and multivalent antigen strategies for vaccine design: Lessons learned and opportunities. [PDF]

Hum Vaccin Immunother
Adjei-Gati E, Quaye CNO, Lamptey PO, Oklu LD, Kwofie JN, Hafiz YA, Kusi KA.   +6 more
europepmc   +1 more source

Decoding the human CD4⁺ T cell epitope repertoire for Lassa fever virus reveals T cell-based pan-mammarenavirus vaccine candidates. [PDF]

Cell Rep Med
Lee Y, Siddiqui L, Tarke A, Kim M, Michaelis T, Macias M, Phillips E, Mallal S, Trevizani R, Frazier A, Scheuermann RH, Zuniga A, Zmasek C, Spurgers K, Akintunde G, Stonier SW, Gagliardi TB, Warfield K, Li H, Hastie KM, Saphire EO, Tan GS, Grifoni A, Sette A.   +23 more
europepmc   +1 more source

Household Practices Sustaining Lassa Fever Transmission in Hyperendemic Communities of Edo State, Nigeria

Igbokwe JO, Isere EE, Adeyemi O, Adebayo A, Asogun D, Olayemi A.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection

Cell Host and Microbe, 2022
Andrew Ward, Max Crispin, Khadija Tejjani   +2 more
exaly  

Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus

Emerging Microbes and Infections, 2020
Honoré S Bankolé, Magloire Da Silva, Sylvain Baize   +2 more
exaly  

A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus

Proceedings of the National Academy of Sciences of the United States of America, 2023
Rodrigo Borrega, Robert W Cross, Abhishek N Prasad   +2 more
exaly  

Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies

Cell Reports, 2022
Luis Branco, Erica Ollmann Saphire, Kathryn M Hastie   +2 more
exaly  

Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization

Cell, 2019
Robert W Cross, Luis Branco, Erica Ollmann Saphire   +2 more
exaly  

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever

Clinical Infectious Diseases, 2017
Anita McElroy, Stephan Becker, Timo Wolf
exaly  

Lassa Virus

Critical Reviews in Clinical Laboratory Sciences, 2004
Stephan Günther
exaly